ESC Premium Access

Risk for major adverse cardiovascular events estimated by the TIMI Risk Score for Secondary Prevention TRS2P in patients with coronary artery disease did not impact lipid lowering treatment in clinica

Congress Session

About the speaker

Doctor Anselm Kai Gitt

Klinikum Ludwigshafen, Ludwigshafen (Germany)
12 presentations
0 follower

20 more presentations in this session

Disconcordance between ESC prevention guidelines and observed lipid profiles in patients with known coronary artery disease

Speaker: Doctor I. Dykun (Essen, DE)

Thumbnail

Statin treatment after acute coronary syndrome: long-term persistence and reasons for non-persistence

Speaker: Doctor D. Huber (Umea, SE)

Thumbnail

Predictive value of omega-3 polyunsaturated fatty acids (PUFAs) for cardiovascular- and all-cause mortality in chronic haemodialysis patients

Speaker: Doctor Y. Kumada (Kasamatsu, JP)

Thumbnail

The association between apolipoprotein A1 and HDL-cholesterol with acute myocardial infarction is modified by plasma choline. A cohort study of patients with suspected stable angina pectoris

Speaker: Doctor G. Svingen (Bergen, NO)

Thumbnail

Post-prandial remnant lipoprotein metabolism in sitosterolemia

Speaker: Doctor H. Tada (Kanazawa, JP)

Thumbnail

Access the full session

Poster Session 6 - Preventive cardiology / Lipids

Speakers: Doctor A. Gitt, Doctor I. Dykun, Doctor D. Huber, Doctor Y. Kumada, Doctor G. Svingen...
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

This platform is supported by

logo Novo Nordisk